Edition:
India

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

10.26USD
16 Aug 2019
Change (% chg)

$0.49 (+5.02%)
Prev Close
$9.77
Open
$9.85
Day's High
$10.27
Day's Low
$9.72
Volume
47,990
Avg. Vol
84,685
52-wk High
$15.30
52-wk Low
$8.51

About

Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of orphan diseases. Its pipeline includes Sarasar (lonafarnib) for hepatitis delta virus (HDV), exendin (9-39) for severe... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $274.17
Shares Outstanding(Mil.): 24.44
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates